A suspension for injection, each 5 ml dose containing:

Each dose also contains the adjuvant Aluminium hydroxide (less than 15 mg aluminium) and the excipient Thiomersal (0.01% w/v).

A combined E. coli and C. perfringens Type B, C and D vaccine for pigs. For the passive protection of piglets by the active immunisation of breeding sows and gilts to prevent neonatal colibacillosis caused by K99 bearing strains of E. coli; to reduce neonatal colibacillosis caused by K88ab, K88ac and 987P bearing strains of E. coli and C. perfringens Type C necrotising infectious enteritis.

Sows and gilts: 5 ml.

By subcutaneous injection preferably behind the ear. The bottle should be well shaken before the vaccine is withdrawn.

The initial course consists of two doses:

First dose: given at service or, if necessary, at any time up to 6 weeks before farrowing.

Second dose: given two weeks before farrowing is expected.

Given two weeks before farrowing is expected.

Vaccinate only healthy animals.

The vaccine is safe for use during pregnancy. No information is available on specific use during lactation.

Occasional hypersensitivity reactions may occur. Prompt subcutaneous administration of adrenalin may relieve the condition.

Syringes and needles should be sterilised before use and the injection should be made through an area of clean, dry skin, taking precautions against contamination.

In most pigs, a slight to moderate swelling (up to 6 cm) may be seen at the injection site after vaccination. The swelling will decline and disappear but may last from 14 to 21 days in some pigs. No increased reactions have been seen after administration of an overdose.

No information is available on the safety and efficacy from the concurrent use of this vaccine with any other. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Do not mix with any other medicinal products.

Zero days.

Store and transport between +2°C and +8°C. Protect from light. Do not freeze. Use immediately after broaching.

Any unused veterinary medicinal product or waste materials derived from the use of such veterinary medicinal products should be disposed of in accordance with local requirements.

For animal treatment only.

Keep out of reach and sight of children.

50 ml and 100 ml plastic packs.

Not all pack sizes may be marketed.

In any animal population there may be a small number of individuals which fail to respond fully to vaccination. Successful vaccination depends upon correct storage and administration of the vaccine together with the animal's ability to respond. This can be influenced by such factors as genetic constitution, intercurrent infection, age, the presence of maternally-derived antibodies, nutritional status, concurrent drug therapy and stress.